explore -WSS

explore

author：comprehensive 2025-10-02 18:50:04 - browse：69

Mifepristone (Mifeprex) and Misoprostol — A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely. ROBYN BECK/AFP via Getty Images

A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely, partially upholding a lower court’s decision.

The decision from the three-judge panel of the 5th U.S. Circuit Court of Appeals would effectively block mail-order prescriptions of the pill. However, access will remain unchanged for now, as the Supreme Court issued an emergency order this spring to preserve the status quo while the case goes through the appeals process.

The case is all but assured to head to the highest court, which last year overturned Roe v. Wade. Since the ruling, 14 states have implemented abortion bans and another 11 have imposed limits, some up to six weeks of pregnancy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Ask STAT: What do you want to know about ChatGPT in medicine?

WSS

The strategy behind pharma's lawsuits over drug pricing reform

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

WATCH: Why do fingernails fall off when they're damaged?

Ask STAT: What do you want to know about ChatGPT in medicine?

Paxlovid study fails to answer questions over benefit for broader groups

Why drug prescriptions should include diagnoses

entertainment

explore

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

WATCH: Why do fingernails fall off when they're damaged?

Affirmative action in medical school literally saved lives

The science behind Janet Jackson's pregnancy at 49

Medical records are filled with copy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Medicare details structure of new drug price negotiation program

Death of patient in Alzheimer’s trial raises question of possible risks

Psychedelics group wrestles with new pharma identity

CDC concerned about possible undetected monkeypox spread in U.K.

entertainment

Beyond aggravation: Constipation is an American epidemic

With FDA staff opposed to Sarepta therapy, top official intervened

Stroke rates rising, especially in working

Pharma’s losing bet in New Jersey

Cloning humans is technically possible. It's curious no one has tried

3 hurdles to bringing medical devices to the U.S. market

entertainment

hotspot

leisure time

leisure time